These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24859727)

  • 1. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications.
    Walsh J; Jenkins RE; Wong M; Olayanju A; Powell H; Copple I; O'Neill PM; Goldring CE; Kitteringham NR; Park BK
    J Proteomics; 2014 Aug; 108(100):171-87. PubMed ID: 24859727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.
    Yates MS; Tran QT; Dolan PM; Osburn WO; Shin S; McCulloch CC; Silkworth JB; Taguchi K; Yamamoto M; Williams CR; Liby KT; Sporn MB; Sutter TR; Kensler TW
    Carcinogenesis; 2009 Jun; 30(6):1024-31. PubMed ID: 19386581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Point Mutation at C151 of
    Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW
    Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice.
    Osburn WO; Yates MS; Dolan PD; Chen S; Liby KT; Sporn MB; Taguchi K; Yamamoto M; Kensler TW
    Toxicol Sci; 2008 Jul; 104(1):218-27. PubMed ID: 18417483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 induces fibroblast growth factor 21 in diabetic mice.
    Furusawa Y; Uruno A; Yagishita Y; Higashi C; Yamamoto M
    Genes Cells; 2014 Dec; 19(12):864-78. PubMed ID: 25270507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses In Vivo.
    Wible RS; Tran QT; Fathima S; Sutter CH; Kensler TW; Sutter TR
    Mol Pharmacol; 2018 Apr; 93(4):297-308. PubMed ID: 29367259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic or pharmacologic activation of Nrf2 signaling fails to protect against aflatoxin genotoxicity in hypersensitive GSTA3 knockout mice.
    Kensler KH; Slocum SL; Chartoumpekis DV; Dolan PM; Johnson NM; Ilic Z; Crawford DR; Sell S; Groopman JD; Kensler TW; Egner PA
    Toxicol Sci; 2014 Jun; 139(2):293-300. PubMed ID: 24675090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the multiple sensor mechanism of the Keap1-Nrf2 system.
    Takaya K; Suzuki T; Motohashi H; Onodera K; Satomi S; Kensler TW; Yamamoto M
    Free Radic Biol Med; 2012 Aug; 53(4):817-27. PubMed ID: 22732183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
    To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
    Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
    Yates MS; Kwak MK; Egner PA; Groopman JD; Bodreddigari S; Sutter TR; Baumgartner KJ; Roebuck BD; Liby KT; Yore MM; Honda T; Gribble GW; Sporn MB; Kensler TW
    Cancer Res; 2006 Feb; 66(4):2488-94. PubMed ID: 16489057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity.
    Casares L; Moreno R; Ali KX; Higgins M; Dayalan Naidu S; Neill G; Cassin L; Kiib AE; Svenningsen EB; Minassi A; Honda T; Poulsen TB; Wiel C; Sayin VI; Dinkova-Kostova AT; Olagnier D; de la Vega L
    Redox Biol; 2022 May; 51():102291. PubMed ID: 35313207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defence response pathway in CD-1 mice.
    Randle LE; Goldring CE; Benson CA; Metcalfe PN; Kitteringham NR; Park BK; Williams DP
    Toxicology; 2008 Jan; 243(3):249-60. PubMed ID: 18078705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bardoxolone methyl prevents metabolic dysfunction-associated steatohepatitis by inhibiting macrophage infiltration.
    Onuma K; Watanabe K; Isayama K; Ogi S; Tokunaga Y; Mizukami Y
    Br J Pharmacol; 2024 Aug; 181(15):2545-2565. PubMed ID: 38599607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species.
    Reisman SA; Yeager RL; Yamamoto M; Klaassen CD
    Toxicol Sci; 2009 Mar; 108(1):35-47. PubMed ID: 19129213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Keap1-Nrf2 system prevents onset of diabetes mellitus.
    Uruno A; Furusawa Y; Yagishita Y; Fukutomi T; Muramatsu H; Negishi T; Sugawara A; Kensler TW; Yamamoto M
    Mol Cell Biol; 2013 Aug; 33(15):2996-3010. PubMed ID: 23716596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN.
    Pitha-Rowe I; Liby K; Royce D; Sporn M
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5339-47. PubMed ID: 19494206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock.
    Noel S; Zheng L; Navas-Acien A; Fuchs RJ
    Shock; 2014 Nov; 42(5):392-9. PubMed ID: 25105464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites.
    Wong MH; Bryan HK; Copple IM; Jenkins RE; Chiu PH; Bibby J; Berry NG; Kitteringham NR; Goldring CE; O'Neill PM; Park BK
    J Med Chem; 2016 Mar; 59(6):2396-409. PubMed ID: 26908173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bardoxolone methyl inhibits the infection of rabies virus via Nrf2 pathway activation in vitro.
    Chi YL; Xie Y; Liu SQ; Zhu WY
    Virol J; 2023 Nov; 20(1):258. PubMed ID: 37950261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 2A5 constitutive expression and induction by heavy metals is dependent on redox-sensitive transcription factor Nrf2 in liver.
    Lämsä V; Levonen AL; Leinonen H; Ylä-Herttuala S; Yamamoto M; Hakkola J
    Chem Res Toxicol; 2010 May; 23(5):977-85. PubMed ID: 20402460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.